Valbenazine is effective in improving symptoms of chorea for patients with Huntington s disease, without any increase in suicidal ideation or suicidal behavior, phase 3 trial results show.
A new drug has proven beneficial in treating a movement disorder commonly associated with Huntington's disease, according to a recent international study led by UTHealth Houston researcher Erin Furr Stimming, MD, who served as principal investigator on behalf of the KINECT-HD Huntington Study Group.